Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04207749 · ClinicalTrials.gov registry record · NA
Clinical Evaluation of a Daily Wear Silicone Hydrogel Lens
A NA study, sponsored by Alcon Research.
- Completed
- Registry status
- NA
- Development phase
- 249
- Enrollment target
NCT04207749: Completed NA study, sponsored by Alcon Research.
NCT04207749 is a NA study that has completed, run by Alcon Research. The registered enrollment target is 249 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04207749, a NA study, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 249 participants
- Enrollment target
Study Summary
The purpose of this clinical study is to assess the safety and performance of an investigational soft contact lens compared to a commercially available soft contact lens when worn in a daily wear modality with frequent replacement.
Primary Outcome
Visual acuity (VA) was assessed for each eye individually with study lenses in place using a letter chart. VA was collected in Snellen and converted to logarithm minimum angle of resolution (logMAR). A logMAR value of 0 equates to 20/20 Snellen visual acuity (normal distance eyesight), with lower logMAR values indicating better visual acuity.
Interventions
- DEVICE Comfilcon A contact lenses
- DEVICE CLEAR CARE
- DEVICE LID015385 contact lenses
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 249 participants |
| Start Date | 2020-01-22 |
| Est. Completion | 2020-12-17 |
| Phase | NA |
What the finished NCT04207749 record still lists
NCT04207749 is an interventional study that assigns participants to a tested intervention. The registered 249 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower).
The record links to 0 conditions, and to 3 interventions - of which Comfilcon A contact lenses is the first listed.
NCT04207749 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04207749 about?
NCT04207749 is a clinical study titled "Clinical Evaluation of a Daily Wear Silicone Hydrogel Lens". The purpose of this clinical study is to assess the safety and performance of an investigational soft contact lens compared to a commercially available soft contact lens when worn in a daily wear modality with frequent replacement.
What is the current status of trial NCT04207749?
This trial is currently completed. It is a NA study. The enrollment target is 249 participants. The study started on 2020-01-22. Estimated completion is 2020-12-17.
What interventions are being tested in trial NCT04207749?
The interventions under investigation include: Comfilcon A contact lenses (DEVICE), CLEAR CARE (DEVICE), LID015385 contact lenses (DEVICE).
Who is sponsoring clinical trial NCT04207749?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04207749's enrollment target sits among peer trials
249 434th of 2000 higher than 1,567 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04628767 · 249 participants · Phase 2
Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer
- NCT05834907 · 249 participants · NA
Hands and Hearts Together
- NCT06067555 · 249 participants · Early Phase 1
Intradermal Influenza Vaccination
- NCT06588478 · 249 participants · Phase 2
A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI